Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study

Synapse. 2000 Nov;38(2):138-43. doi: 10.1002/1098-2396(200011)38:2<138::AID-SYN4>3.0.CO;2-7.

Abstract

[(11)C]raclopride binding to D2 dopamine receptors in the striatum is sensitive to drug-induced changes of endogenous dopamine concentration. We recently developed the new radioligand [(11)C]FLB 457, which is suitable for positron emission tomography (PET) studies of extrastriatal D2 dopamine receptors. The purpose of this PET study was to examine the effect of amphetamine on [(11)C]FLB 457 binding in extrastriatal regions. Each of three cynomolgus monkeys was examined at baseline conditions, 15 min and 3 h after I.V. injection of amphetamine (2 mg/kg). The effect of amphetamine was calculated from the ratio of specific [(11)C]FLB 457 binding to the binding in the cerebellum, a region which was used as reference for free and nonspecific binding in the brain. The changes of the ratio in the striatum, the thalamus, and the neocortex were between -1.2% and -15.5% at 15 min and -2.1% and -16.3% at 3 h, respectively, after amphetamine administration. The reductions of the binding ratios in the extrastriatal regions are similar to those reported for [(11)C]raclopride binding in the striatum. These data in a limited series of monkeys suggest that [(11)C]FLB 457 binding to D2 dopamine receptors in extrastriatal regions is sensitive to changes in the concentration of endogenous dopamine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphetamine / pharmacology*
  • Animals
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism*
  • Dopamine / metabolism
  • Dopamine Agents / pharmacology*
  • Macaca fascicularis
  • Neocortex / drug effects
  • Neocortex / metabolism*
  • Pyrrolidines / metabolism*
  • Receptors, Dopamine D2 / drug effects
  • Receptors, Dopamine D2 / metabolism*
  • Salicylamides / metabolism*
  • Thalamus / drug effects
  • Thalamus / metabolism*
  • Tomography, Emission-Computed

Substances

  • Dopamine Agents
  • Pyrrolidines
  • Receptors, Dopamine D2
  • Salicylamides
  • FLB 457
  • Amphetamine
  • Dopamine